Apotex to report fiscal 2027 Q2 results Nov. 12
Apotex said it will release its second-quarter fiscal 2027 financial results on Nov. 12, 2026, followed by a conference call and webcast.
TORONTO, Oct. 8, 2026 /CNW/ -- Apotex Health Corp. m. ET.
m. ET. A live webcast of the call will be available at The call can also be accessed live by dialing 416-945-7677 locally or 1-888-699-1199 toll-free from North America. Following the conclusion of the call, a replay of the webcast will be available on Apotex's website.
About Apotex Apotex is a Canadian-based global health company. We improve everyday access to affordable, innovative medicines and health products for millions of people around the world, with a broad portfolio of generic, biosimilar, and innovative branded pharmaceuticals, and consumer health products. Headquartered in Toronto, with regional offices globally, including in the United States, Mexico, and India, we are the largest Canadian-based pharmaceutical company and a health partner of choice for the Americas for pharmaceutical licensing and product acquisitions. Learn more at SOURCE Apotex Health Corp.
/CONTACT Copyright CNW Group 2026 (END) Dow Jones Newswires October 08, 2026 16:52 ET (20:52 GMT) The statements in this document shall not be considered as an objective or independent explanation of the matters. Please note that this document (a) has not been prepared in accordance with legal requirements designed to promote the independence of investment research, and (b) is not subject to any prohibition on dealing ahead of the dissemination or publication of investment research.